C-PLM2712 North Inc
mitochondrial medicine, AI discovery, bifurcated stress response
modulatingsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-PLM2
C-PLM2C-PLM2mitochondrial medicine, AI discovery, bifurcated stress response
0-100 chain-logic scale · 15 dimensions · scored on public evidence
712 North Inc mitochondrial medicine, AI discovery, bifurcated stress response
712 North Inc says it is pioneering personalized mitochondrial medicines for age-related diseases. Its stated focus is targeting a bifurcated stress response that promotes cancer survival while triggering neurodegenerative and cardiovascular cell death. The site also says AI drives its discovery and cuts overhead.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
712 North Inc — Early mechanism · Lower middle. Derived deterministically from 4 extracted project(s). Most-advanced status: preclinical. Band: early_mechanism. Aging-relevance not LLM-reviewed in this pass.
Source: Deterministic